Tom Hannan

Tom Hannan is an Instructor in the Department of Pathology & Immunology at Washington University School of Medicine, with a joint appointment as Chief Scientific Officer at Fimbrion Therapeutics since 2016. His research examines mucosal immune defense mechanisms in urinary tract infections.

Education

• B.S. Biology, Georgetown University (1989)
• D.V.M. Veterinary Medicine, Tufts University Cummings School of Veterinary Medicine (1995)
• Ph.D. Molecular Microbiology and Microbial Pathogenesis, Washington University in St. Louis (2008)

Research Focus

Dr. Hannan investigates host-pathogen interactions in recurrent urinary tract infections, specializing in bladder mucosal immunity, uropathogenic E. coli colonization mechanisms, and neuroimmune responses to chronic infection.